Geographical and socioeconomic disparities in post-transcatheter aortic valve replacement pacemaker placement

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Bilal Hussain , Sanchit Duhan , Ahmed Mahmood , Luay Al-Alawi , Mian Muhammad Salman Aslam , Christel Cuevas , Thomas Alexander , Mohammad M. Ansari , Fahad Waqar
{"title":"Geographical and socioeconomic disparities in post-transcatheter aortic valve replacement pacemaker placement","authors":"Bilal Hussain ,&nbsp;Sanchit Duhan ,&nbsp;Ahmed Mahmood ,&nbsp;Luay Al-Alawi ,&nbsp;Mian Muhammad Salman Aslam ,&nbsp;Christel Cuevas ,&nbsp;Thomas Alexander ,&nbsp;Mohammad M. Ansari ,&nbsp;Fahad Waqar","doi":"10.1016/j.carrev.2024.04.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Pacemaker (PPM) implantation is indicated for conduction abnormalities which can develop post-transcatheter aortic valve replacement (TAVR). However, whether post-TAVR PPM<span> risk is associated with the geographical location of the hospital and socioeconomic status of the patient is not well established. Our goal was to explore geographical and socioeconomic disparities in post-TAVR PPM implantation.</span></div></div><div><h3>Methods</h3><div><span>A retrospective cohort analysis was conducted using the National Inpatient Sample 2016–2020 with respective ICD-10 codes for TAVR and PPM implantation. A weighted multivariate </span>logistic regression model was used to analyze prognostic outcomes.</div></div><div><h3>Results</h3><div>The number of patients hospitalized for undergoing TAVR was 296,740, out of which 28,265 patients had PPM implantation (prevalence 9.5 %). Patients' demographics including sex, ethnicity, household income, and insurance were not associated with risk of post-TAVR PPM except age (OR 1.01, CI 1.07–12.5, p &lt; 0.001). Compared to rural hospitals, urban non-teaching hospitals were associated with a higher risk of post-TAVR PPM (OR 2.09, 1.3–3.43, p = 0.003). Compared to New England hospitals (ME, NH, VT, MA, RI, CT), middle Atlantic hospitals (NY, NJ, PA) were associated with highest post-TAVR PPM risk (OR 1.54, CI 1.2–1.98, p &lt; 0.001), followed by Pacific (AK, WA, OR, CA, HI), mountain (ID, MT, WY, NV, UT, CO, AZ, NM) and east north central US.</div></div><div><h3>Conclusion</h3><div>Patients' demographics including sex, ethnicity, household income, and insurance were not associated with the risk of post-TAVR PPM except for age. Compared to New England hospitals, Middle Atlantic hospitals were associated with the highest post-TAVR PPM risk followed by Pacific, Mountain, and East North Central US. Prospective studies with data on TAVR wait times, expertise of the interventional staff, and post-TAVR management and discharge planning are required to further explore the observed regional distribution of TAVR outcomes.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"68 ","pages":"Pages 86-91"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838924001532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Pacemaker (PPM) implantation is indicated for conduction abnormalities which can develop post-transcatheter aortic valve replacement (TAVR). However, whether post-TAVR PPM risk is associated with the geographical location of the hospital and socioeconomic status of the patient is not well established. Our goal was to explore geographical and socioeconomic disparities in post-TAVR PPM implantation.

Methods

A retrospective cohort analysis was conducted using the National Inpatient Sample 2016–2020 with respective ICD-10 codes for TAVR and PPM implantation. A weighted multivariate logistic regression model was used to analyze prognostic outcomes.

Results

The number of patients hospitalized for undergoing TAVR was 296,740, out of which 28,265 patients had PPM implantation (prevalence 9.5 %). Patients' demographics including sex, ethnicity, household income, and insurance were not associated with risk of post-TAVR PPM except age (OR 1.01, CI 1.07–12.5, p < 0.001). Compared to rural hospitals, urban non-teaching hospitals were associated with a higher risk of post-TAVR PPM (OR 2.09, 1.3–3.43, p = 0.003). Compared to New England hospitals (ME, NH, VT, MA, RI, CT), middle Atlantic hospitals (NY, NJ, PA) were associated with highest post-TAVR PPM risk (OR 1.54, CI 1.2–1.98, p < 0.001), followed by Pacific (AK, WA, OR, CA, HI), mountain (ID, MT, WY, NV, UT, CO, AZ, NM) and east north central US.

Conclusion

Patients' demographics including sex, ethnicity, household income, and insurance were not associated with the risk of post-TAVR PPM except for age. Compared to New England hospitals, Middle Atlantic hospitals were associated with the highest post-TAVR PPM risk followed by Pacific, Mountain, and East North Central US. Prospective studies with data on TAVR wait times, expertise of the interventional staff, and post-TAVR management and discharge planning are required to further explore the observed regional distribution of TAVR outcomes.
经导管主动脉瓣置换术后起搏器安置的地域和社会经济差异。
导言:植入起搏器(PPM)适用于经导管主动脉瓣置换术(TAVR)后可能出现的传导异常。然而,经导管主动脉瓣置换术后出现传导异常的风险是否与医院的地理位置和患者的社会经济状况有关,目前尚无定论。我们的目标是探索 TAVR 术后 PPM 植入的地域和社会经济差异:我们使用 2016-2020 年全国住院患者样本进行了回顾性队列分析,并分别对 TAVR 和 PPM 植入术进行了 ICD-10 编码。采用加权多变量逻辑回归模型分析预后结果:接受 TAVR 的住院患者人数为 296,740 人,其中 28,265 人接受了 PPM 植入术(发病率为 9.5%)。除年龄外,患者的性别、种族、家庭收入和保险等人口统计学特征与TAVR术后PPM风险无关(OR 1.01,CI 1.07-12.5,P 结论:TAVR术后PPM风险与患者的性别、种族、家庭收入和保险等人口统计学特征无关:除年龄外,患者的人口统计学特征(包括性别、种族、家庭收入和保险)与 TAVR 术后 PPM 风险无关。与新英格兰地区的医院相比,中大西洋地区的医院TAVR术后PPM风险最高,其次是太平洋地区、山区和美国东北部地区。需要进行前瞻性研究,收集有关 TAVR 等待时间、介入人员的专业知识以及 TAVR 术后管理和出院计划的数据,以进一步探讨所观察到的 TAVR 结果的地区分布。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Revascularization Medicine
Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.90%
发文量
687
审稿时长
36 days
期刊介绍: Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信